Quinoxaline compound, liquid crystal composition containing the compound, liquid crystal device using the composition, display apparatus and display method

Information

  • Patent Grant
  • 5512209
  • Patent Number
    5,512,209
  • Date Filed
    Tuesday, April 26, 1994
    30 years ago
  • Date Issued
    Tuesday, April 30, 1996
    28 years ago
Abstract
A quinoxaline compound of the formula (I) according to claim 1 characterized by having at least one quinoxaline-2,6 (or 2,7)-diyl group is suitable as a component for a liquid crystal composition providing improved response characteristics and a high contrast. A liquid crystal device is constituted by disposing the liquid crystal composition between a pair of electrode plates. The liquid crystal device is used as a display panel constituting a display apparatus providing good display characteristics.
Description

FIELD OF THE INVENTION AND RELATED ART
The present invention relates to a quinoxaline compound, a liquid crystal composition, a liquid crystal device, a display apparatus and a display method, and more particularly to a quinoxaline compound, a liquid crystal composition containing the compound with improved responsiveness to an electric field, a liquid crystal device using the composition for use in a display device, a liquid crystal-optical shutter etc a display apparatus using the device and a display method of using the composition or device.
Hitherto, liquid crystal devices have been used as an electro-optical device in various fields. Most liquid crystal devices which have been put into practice use TN (twisted nematic) type liquid crystals, as shown in "Voltage-Dependent Optical Activity of a Twisted Nematic Liquid Crystal" by M. Schadt and W. Helfrich "Applied Physics Letters" Vol. 18, No. 4 (Feb. 15, 1971) pp. 127-128.
These devices are based on the dielectric alignment effect of a liquid crystal and utilize an effect that the average molecular axis direction is directed to a specific direction in response to an applied electric field because of the dielectric anisotropy of liquid crystal molecules. It is said that the limit of response speed is on the order of .mu.sec, which is too slow for many uses. On the other hand, a simple matrix system of driving is most promising for application to a large-area flat display in view of cost, productivity, etc., in combination. In the simple matrix system, an electrode arrangement wherein scanning electrodes and signal electrodes are arranged in a matrix, and for driving, a multiplex driving scheme is adopted wherein an address signal is sequentially, periodically and selectively applied to the scanning electrodes and prescribed data signals are selectively applied in parallel to the signal electrodes in synchronism with the address signal.
When the above-mentioned TN-type liquid crystal is used in a device of such a driving system, a certain electric field is applied to regions where a scanning electrode is selected and signal electrodes are not selected (or regions where a scanning electrode is not selected and a signal electrode is selected), which regions are called "half-selected points". If the difference between a voltage applied to the selected points and a voltage applied to the half-selected points is sufficiently large, and a voltage threshold level required for allowing liquid crystal molecules to be aligned or oriented perpendicular to an electric field is set to a value therebetween, display devices normally operate. However, in fact, as the number (N) of scanning lines increases, a time (duty ratio) during which an effective electric field is applied to one selected point when a whole image area (corresponding to one frame) is scanned decreases with a ratio of 1/N. Accordingly, the larger the number of scanning lines are, the smaller is the voltage difference of an effective value applied to a selected point and non-selected points when scanning is repeatedly effected. This leads to unavoidable drawbacks of lowering of image contrast or occurrence of interference or crosstalk. These phenomena are regarded as essentially unavoidable problems appearing when a liquid crystal having no bistability (i.e. liquid crystal molecules are horizontally oriented with respect to the electrode surface as stable state and is vertically oriented with respect to the electrode surface only when an electric field is effectively applied) is driven (i.e. repeatedly scanned) by making use of a time storage effect. To overcome these drawbacks, the voltage averaging method, the two-frequency driving method, the multiple matrix method, etc. have been already proposed. However, any method is not sufficient to overcome the above-mentioned drawbacks. As a result, the development of large image area or high packaging density in respect to display elements is delayed because it is difficult to sufficiently increase the number of scanning lines.
To overcome drawbacks with such prior art liquid crystal devices, the use of liquid crystal devices having bistability has been proposed by Clark and Lagerwall (e.g. Japanese Laid-Open Patent Appln. No. 56-107216; U.S. Pat. No. 4,367,924, etc.). In this instance, as the liquid crystals having bistability, ferroelectric liquid crystals having chiral smectic C-phase (SmC*) or H-phase (SmH*) are generally used. These liquid crystals have bistable states of first and second stable states with respect to an electric field applied thereto. Accordingly, as different from optical modulation devices in which the above-mentioned TN-type liquid crystals are used, the bistable liquid crystal molecules are oriented to first and second optically stable states with respect to one and the other electric field vectors, respectively. Further, this type of liquid crystal has a property (bistability) of assuming either one of the two stable states in response to an applied electric and retaining the resultant state in the absence of an electric field.
In addition to the above-described characteristic of showing bistability, such a ferroelectric liquid crystal (hereinafter sometimes abbreviated as "FLC") has an excellent property, i.e., a high-speed responsiveness. This is because the spontaneous polarization of the ferroelectric liquid crystal and an applied electric field directly interact with each other to induce transition of orientation states. The resultant response speed is faster than the response speed due to the interaction between dielectric anisotropy and an electric field by 3 to 4 digits.
Thus, a ferroelectric liquid crystal potentially has very excellent characteristics, and by making use of these properties, it is possible to provide essential improvements to many of the above-mentioned problems with the conventional TN-type devices. Particularly, the application to a high-speed optical shutter and a display of a high density and a large picture is expected. For this reason, there has been made extensive research with respect to liquid crystal materials showing ferroelectricity. However, previous ferroelectric liquid crystal materials do not sufficiently satisfy characteristics required for a liquid crystal device including low-temperature operation characteristic, high-speed responsiveness, high contrast, etc.
More specifically, among a response time .tau., the magnitude of spontaneous polarization Ps and viscosity .eta., the following relationship (II) exists: .tau.=.eta./(Ps.E) . . . (II), where E is an applied voltage. Accordingly, a high response speed can be obtained by (a) increasing the spontaneous polarization Ps, (b) lowering the viscosity .eta., or (c) increasing the applied voltage E. However, the driving voltage has a certain upper limit in view of driving with IC, etc., and should desirably be as low as possible. Accordingly, it is actually necessary to lower the viscosity or increase the spontaneous polarization.
A ferroelectric chiral smectic liquid crystal having a large spontaneous polarization generally provides a large internal electric field in a cell given by the spontaneous polarization and is liable to pose many constraints on the device construction giving bistabitity. Further, an excessively large spontaneous polarization is liable to accompany an increase in viscosity, so that remarkable increase in response speed may not be attained as a result.
Moreover, if it is assumed that the operation temperature of an actual display device is 5.degree.-40.degree. C., the response speed changes by a factor of about 20, so that it actually exceeds the range controllable by driving voltage and frequency.
In general, in a liquid crystal device utilizing birefringence of a liquid crystal, the transmittance under right angle cross nicols is given by the following equation:
I/I.sub.0 =sin.sup.2 4.theta..sin.sup.2 (.DELTA.nd/.lambda.).pi.,
wherein I.sub.0 : incident light intensity,
I: transmitted light intensity,
.theta.: tilt angle,
.DELTA.n: refractive index anisotropy,
d: thickness of the liquid crystal layer,
.lambda.: wavelength of the incident light.
Tilt angle .theta. in a ferroelectric liquid crystal with non-helical structure is recognized as a half of an angle between the average molecular axis directions of liquid crystal molecules in a twisted alignment in a first orientation state and a second orientation state. According to the above equation, it is shown that a tilt angle .theta. of 22.5 degrees provides a maximum transmittance and the tilt angle .theta. in a non-helical structure for realizing bistability should desirably be as close as possible to 22.5 degrees in order to provide a high transmittance and a high contrast.
However, when a birefringence of a liquid crystal is utilized in a liquid crystal device using a ferroelectric liquid crystal in a non-helical structure exhibiting bistability reported by Clark and Lagerwall, the following problems are encountered, thus leading to a decrease in contrast.
First, a tile angle .theta. in a ferroelectric liquid crystal with a non-helical structure obtained by alignment with a polyimide film treated by rubbing of the prior art has become smaller as compared with a tilt angle H (the angle H is a half of the apex angle of the cone shown in FIG. 4 as described below) in the ferroelectric liquid crystal having a helical structure, thus resulting in a lower transmittance.
Secondly, even if the device provides a high contrast in a static state, i.e., under no electric field application, liquid crystal molecules fluctuate due to a slight electric field at a non-selection period of time in a matrix drive scheme in the case of applying a voltage to the liquid crystal molecules for providing a display image, thus resulting in the display image including a light for pale) black display state, i.e., a decrease in a contrast.
Thus, as described hereinabove, commercialization of a ferroelectric liquid crystal device requires a liquid crystal composition assuming a chiral smectic phase which provides a high contrast, a high-speed responsiveness and a small temperature-dependence of response speed.
In order to afford uniform switching characteristics at display, a good view-angle characteristic, a good storage stability at a low temperature, a decrease in a load to a driving IC (integrated circuit), etc. to the above-mentioned ferroelectric liquid crystal device or a display apparatus including the ferroelectric liquid crystal device, the above-mentioned liquid crystal composition is required to optimize its properties such as spontaneous polarization, an chiral smectic C (SmC*) pitch, a cholesteric (Ch) pitch, a temperature range showing a mesomorphic phase, optical anisotropy, a tilt angle and dielectric anisotropy.
SUMMARY OF THE INVENTION
An object of the present invention is to provide a compound, particularly a mesomorphic compound providing a high speed responsiveness, a high contrast and a decreased temperature-dependence of response speed; a liquid crystal composition, particularly a chiral smectic liquid crystal composition containing the (mesomorphic) compound for providing a practical ferroelectric liquid crystal device as described above; a liquid crystal device including the liquid crystal composition and affording good display performances; a display apparatus including the device, and a display method using the composition or device.
According to the present invention, there is provided a quinoxaline compound represented by the following formula (I):
R.sub.1 --A.sub.1 --X.sub.1 --A.sub.2 --X.sub.2 --A.sub.3 --R.sub.2(I),
wherein
R.sub.1 and R.sub.2 independently denote halogen or a linear or branched alkyl group having 2-18 carbon atoms capable of including one or non-neighboring two or more --CH.sub.2 -- groups which can be replaced with --O--, --S--, --CO--, --CO--O--, --0--CO--, --CH.dbd.CH-- or --C.ident.C--; the linear or branched alkyl group being capable of including hydrogen which can be replaced with fluorine;
X.sub.1 and X.sub.2 independently denote a single bond, --CO--O--, --O--CO--, --CH.sub.2 O--, --OCH.sub.2 --, --CH.sub.2 CH.sub.2 -- or --C.ident.C--;
A.sub.1, A.sub.2 and A.sub.3 independently denote a single bond, 1,4-phenylene, 1-4-phenylene having one or two substituents comprising F, Cl, Br, CH.sub.3, CF.sub.3 or CN, 1,4-cyclohexylene, pyrimidine-2,5-diyl, pyridine-2,5-diyl, thiophene-2,5-diyl, 2,6-naphthylene, thiazole-2,5-diyl, thiadiazole-2,5-diyl, pyrazine-2,5-diyl, pyridazine-3,6-diyl, benzothiazole-2,6-diyl, benzoxazole-2,5-diyl, indan-2,5-diyl, 2-alkylindan-2,5-diyl having a linear or branched alkyl group having 1-18 carbon atoms, coumaran-2,5-diyl, 2-alkylcoumaran-2,5-diyl having a linear or branched alkyl group having 1-18 carbon atoms, quinoxaline-2,6-diyl or quinoxaline-2,7-diyl; with the proviso that:
at least one group of A.sub.1, A.sub.2 and A.sub.3 is quinoxaline-2,6-diyl or quinoxaiine-2,7-diyl and the remaining two groups of A.sub.1, A.sub.2 and A.sub.3 cannot be a single bond simultaneously; and when A.sub.1 or A.sub.3 is quinoxaline-2,6-diyl and A.sub.2 is 1,4-phenylene, then the remaining A.sub.1 or A.sub.3 cannot be 1,4-phenylene.
According to the present invention, there is further provided a liquid crystal composition containing at least one species of the above-mentioned quinoxaline compound.
The present invention provides a liquid crystal device including the liquid crystal composition, particularly a liquid crystal device comprising a pair of electrode plates and the liquid crystal composition described above disposed between the electrode plates.
The present invention further provides a display apparatus including a display panel comprising the liquid crystal device.
The present invention still further provides a display method using the liquid crystal composition or the liquid crystal device described above and controlling the alignment direction of liquid crystal molecules in accordance with image data thereby to obtain a desired display image.
Heretofore, there have been known (mesomorphic) compounds having a quinoxaline ring as disclosed in H. Schubert et al., "J. Prakt. Chem.", 33, 265 (1966), S. Diele et al., "Mol. Cryst. Liq. Cryst.", 17, 167 (1972), Dvolaitzky M. et al., "Tetrahedron", 32, 1835 (1976) and J. Herrmann et al., "Z. Phys. Chem. (Leipzig)", 257, 563 (1976).
All of these compounds, however, have a 2-substituted quinoxaline ring as a terminal group. Accordingly, the above documents do not disclose a quinoxaline compound of the formula (I) according to the present invention characterized by having quinoxaline-2,6-diyl or quinoxaline-2,7-diyl. The compounds of the above documents generally have a higher clearing point even if the compounds show a mesomorphic phase. In addition, such compounds are expected to have a poor compatibility with another mesomorphic compound as a component of a liquid crystal composition because such compounds contains a quinoxaline ring in which 6- or 7-position thereof is not substituted. Thus, the compounds as disclosed in the above-mentioned documents are believed to be not suitable for a component of a liquid crystal composition when compared with the quinoxaline compound of the formula (I) of the present invention.
We have found that a quinoxaline compound, preferably a mesomorphic quinoxaline compound, represented by the formula (I) having at least one 2,6- or 2,7-quinoxaline ring in a prescribed position provides a wider temperature range showing a mesomorphic phase, a good compatibility with another compound and a low viscosity, and thus is suitable as a component of a liquid crystal composition, particularly a ferroelectric chiral smectic liquid crystal composition and a liquid crystal device including the liquid crystal composition which provide good display characteristics based on improvements in various characteristics such as an alignment characteristic, switching characteristic, responsiveness, a temperature-dependence of response speed, and a contrast. As the quinoxaline compound of the formula (I) according to the present invention has a good compatibility with another (mesomorphic) compound used herein, it is possible to use the quinoxaline compound of the formula (I) for controlling various properties such as spontaneous polarization, SmC* pitch, Ch pitch, a temperature range showing a mesomorphic phase, optical anisotropy, a tilt angle and dielectric anisotropy, with respect to a liquid crystal mixture or composition.
These and other objects, features and advantages of the present invention will become more apparent upon a consideration of the following description of the preferred embodiments of the present invention taken in conjunction with the accompanying drawings.





BRIEF DESCRIPTION OF THE DRAWINGS
FIG. 1 is a schematic sectional view of a liquid crystal device using a liquid crystal composition assuming a chiral smectic phase;
FIGS. 2 and 3 are schematic perspective views of a device cell embodiment for illustrating the operation principle of a liquid crystal device utilizing ferroelectricity of a liquid crystal composition;
FIG. 4 is a schematic view for illustrating a tilt angle H in a ferroelectric liquid crystal with a helical structure.
FIG. 5A shows unit driving waveforms used in an embodiment of the present invention; FIG. 5B is time-serial waveforms comprising a succession of such unit waveforms;
FIG. 6 is an illustration of a display pattern obtained by an actual drive using the time-serial waveforms shown in FIG. 5B;
FIG. 7 is a block diagram showing a display apparatus comprising a liquid crystal device utilizing ferroelectricity of a liquid crystal composition and a graphic controller: and
FIG. 8 is a time chart of image data communication showing time correlation between signal transfer and driving with respect to a liquid crystal display apparatus and a graphic controller.





DETAILED DESCRIPTION OF THE INVENTION
Preferred examples of the quinoxaline compound of the formula (I) may include a quinoxaline compound (Ia) having a single bond as any one of groups A.sub.1, A.sub.2 and A.sub.3, thus having two cyclic groups at least one of which is a 2,6- or 2,7-quinoxaline ring. The quinoxaline compound (Ia) has a relatively lower temperature range of a mesomorphic phase and has a low viscosity, thus particularly being an effective components for improving high-speed responsiveness and a decreased temperature-dependence of response speed of a resultant liquid crystal composition.
Preferred examples of the quinoxaline compound of the formula (I) may .also include quinoxaline compounds (Ib) to (Ie) shown below having three cyclic groups at least one of which is a 2,6- or 2,7-quinoxaline ring.
Compound (Ib) wherein one of A.sub.1 and A.sub.3 is 1,4-phenylene or said 1,4-phenylene having one or two substituents and the other of A.sub.1 and A.sub.3 is quinoxaline-2,6-diyl or quinoxaline-2,7-diyl, and A.sub.2 is selected from pyrimidine-2,5-diyl, pyridine-2,5-diyl, thiadiazole-2,5-diyl, thiazole-2,5-diyl, thiophene-2,5-diyl, pyrazine-2,5-diyl or pyridazine-3,6-diyl;
Compound (Ic) wherein A.sub.2 is 1,4-phenylene or said 1,4-phenylene having one or two substituents, and one of A.sub.1 and A.sub.3 is quinoxaline-2,6-diyl or quinoxaline-2,7-diyl, and the other of A.sub.1 and A.sub.3 is selected from pyrimidine-2,5-diyl, pyridine-2,5-diyl, thiadiazole-2,5-diyl, thiazole-2,5-diyl, thiophene-2,5-diyl, pyrazine-2,5-diyl or pyridazine-3,6-diyl;
Compound (Id) wherein A.sub.2 is quinoxaline-2,6-diyl or quinoxaline-2,7-diyl, and A.sub.1 and A.sub.3 are independently selected from 1,4-phenylene, said 1,4-phenylene having one or two substituents, pyrimidine-2,5-diyl, pyridine-2,5-diyl, thiadiazole-2,5-diyl, thiazole-2,5-diyl, thiophene-2,5-diyl, pyrazine-2,5-diyl or pyridazine-3,6-diyl; and
Compound (Ie) wherein each of A.sub.1 and A.sub.3 is quinoxaline-2,6-diyl or quinoxaline-2,7-diyl, and A.sub.2 is selected from 1,4-phenylene, said 1,4-phenylene having one or two substituents, 1,4-cyclohexylene, pyrimidine-2,5-diyl, pyridine-2,5-diyl, thiadiazole-2,5-diyl, thiazole-2,5-diyl, thiophene-2,5-diyl, pyrazine-2,5-diyl or pyridazine-3,6-diyl.
Each of the above quinolaline compounds (Ib) to (Ie) particularly has a wider temperature range of a mesomorphic phase and is used as a component effective for particularly improving a temperature-dependence of response speed and alignment characteristics of a resultant liquid crystal composition and also effective for constituting a liquid crystal device providing a high contrast.
In the quinoxaline compounds (Ia) to (Ie), further preferred examples of the quinoxaline compoundof the formula (I) may include quinoxaline compounds(Iaa), (Iab) and (Iac) shown below having two cyclicgroups and quinoxaline compounds (Iba) to (Iea) shownbelow having three cyclic groups. These compoundshave a small number of polar linkages, thus beingexpected to have a low viscosity in addition to theabove-mentioned advantages such as a wider mesomorphictemperature range, a good compatibility and goodalignment characteristic.
Compound (Iaa) wherein A.sub.1, X.sub.1 and X.sub.2 are asingle bond, A.sub.2 is selected from 1,4-phenylene, said1,4-phenylene having one or two substituents, 1,4-cyclohexylene,pyrimidine-2,5-diyl, pyridine-2,5-diyl,thiophene-2,5-diyl, 2,6-naphthylene, thiazole-2,5-diyl,thiadiazole-2,5-diyl, pyrazine-2,5-diyl,pyridazine-3,6-diyl, benzothiazole-2,6-diyl orbenzoxazole-2,5-diyl, and A.sub.3 is quinoxaline-2,6-diylor quinoxaline-2,7-diyl;
Compound (Iab) wherein A.sub.1 and X.sub.1 are a singlebond, A.sub.2 is selected from 1,4-phenylene, said 1,4-phenylenehaving one or two substituents or 1,4-cyclohexylene,X.sub.2 is --CO--O-- or --O--CO--; and A.sub.3 isquinoxaline-2,6-diyl or quinoxaline-2,7-diyl;
Compound (Iac) wherein A.sub.1 and X.sub.1 are a singlebond, A.sub.2 is selected from 1,4-phenylene, said 1,4-phenylenehaving one or two substituents, pyrimidine-2,5-diylor pyridine-2,5-diyl, X.sub.2 is --C.ident.C-- or--CH.sub.2 CH.sub.2 --, and A.sub.3 is quinoxaline-2,6-diyl orquinoxaline-2,7-diyl;
Compound (Iba) wherein A.sub.1 is 1,4-phenylene orsaid 1,4-phenylene having one or two substituent, X.sub.1 and X.sub.2 are independently selected from a single bond,--CO--O--, --C.ident.C-- or --CH.sub.2 CH.sub.2 --, A.sub.2 is selected frompyrimidine-2,5-diyl, pyridine-2,5-diyl, thiadiazole-2,5-diyl,thiazole-2,5-diyl, thiophene-2,5-diyl orpyrazine-2,5-diyl, and A.sub.3 is quinoxaline-2,6-diyl orquinoxaline-2,7-diyl;
Compound (Ica) wherein A.sub.1 is selected frompyrimidine-2,5-diyl, pyridine-2,5-diyl, thiadiazole-2,5-diyl,thiazole-2,5-diyl, thiophene-2,5-diyl,pyrazine-2,5-diyl or pyridazine-3,6-diyl, X.sub.1 and X.sub.2 are independently selected from a single bond, --CO--O--,--C.ident.C-- or --CH.sub.2 CH.sub.2 --, A.sub.2 is 1,4-phenylene or said 1,4-phenylenehaving one or two substituents, and A.sub.3 isquinoxaline-2,6-diyl or quinoxaline-2,7-diyl;
Compound (Ida) wherein X.sub.1 and X.sub.2 areindependently selected from a single bond, --C.ident.C-- or--CH.sub.2 CH.sub.2 --, A.sub.2 is quinoxaline-2,6-diyl or quinoxaline-2,7-diyl,A.sub.1 and A.sub.3 are independently selected from1,4-phenylene, said 1,4-phenylene having one or twosubstituents, pyrimidine-2,5-diyl, pyridine-2,5-diyl,thiadiazole-2,5-diyl, thiazole-2,5-diyl, thiophene-2,5-diyl,pyrazine-2,5-diyl or pyridazine-3,6-diyl,
Compound (Iea) wherein X.sub.1 and X.sub.2 are a singlebond, each of A.sub.1 and A.sub.3 is quinoxaline-2,6-diyl orquinoxaline-2,7-diyl, A.sub.2 is selected from 1,4-phenylenesaid 1,4-phenylene having one or twosubstituents, 1,4-cyclohexylene, 2,6-naphthylene,pyrimidine-2,5-diyl, pyridine-2,5-diyl, thiadiazole-2,5-diyl,thiazole-2,5-diyl, thiophene-2,5-diyl,pyrazine-2,5-diyl or pyridazine-3,6-diyl.
When the quinoxaline compound of the formula(I) contains 1,4-phenylene group having one or twosubstituents, preferred examples of the substituentsmay include halogen or trifluoromethyl, particularlyfluorine.
R.sub.1 and R.sub.2 in the formula (I) may preferablybe selected from the following groups (i) to (vi): ##STR1## wherein a is an integer of 2-17; d, g and i are aninteger of 0-7; b, e and h are an integer of 1-8, f and k are 0 or 1, j is an intender of 1-15; and X.sub.3 denotes a single bond, --0--, --O--CO-- or --CO--O--. R.sub.1 andR.sub.2 having the above groups (i) to (vi) may preferablybe used in view of a good mesomorphic characteristic,a low viscosity etc In the case where the abovegroups (ii), (iii) and (v) are optically active, aquinoxaline compound containing such a group issuitable for a chiral dopant.
In the above groups (i) to (v), R.sub.1 and R.sub.2 maymore preferably be the groups (i), (ii), (iv) or (v),particularly (i) or (iv).
X.sub.3 in the above groups (i) to (v) maypreferably be a single bond, --O-- or --O--CO--,particularly a single bond or --O--.
The quinoxaline compound of the formula (I)according to the present invention may for example besynthesized by stirring a mixture of 4-substituted-1,2-phenylenediamine(as a raw material) and 4-substitutedphenylglyoxal in ethanol under heat-refluxing.
The mesomorphic compound of the formula (I)may generally be synthesized through, e.g., thefollowing reaction scheme. ##STR2##
In the above reaction scheme, R.sub.1, R.sub.2, A.sub.1, A.sub.3 and X.sub.1 have the same meanings as those describedabove.
It is possible to prepare a group of R.sub.1 --A.sub.1 --X.sub.1 -- by using 1,4-phenylenediamine having anappropriate group, such as methoxy, acetoxy,benzyloxy, acetyl, nitro, --Br or --I, in 4-positioncapable of being formed into R.sub.1 --A.sub.1 --X.sub.1 -- and effectingring closure to form a quinoxaline ring and thereaftermodifying the appropriate group into the R.sub.1 --A.sub.1 --X.sub.1 --group.
Specific examples of tile quinoxalinecompounds represented by the formula (I) may includethose shown by the following structural formulae. ##STR3##
The liquid crystal composition according tothe present invention may be obtained by mixing atleast one species of the quinoxaline compoundrepresented by the formula (I) and at least onespecies of another mesomorphic compound, preferably 2-50 species of components, more preferably 3-30 species of components, in appropriate proportionsdetermined by taking account of usage or uses of aliquid crystal device using the composition,characteristics required therefor, etc.
The liquid crystal composition according tothe present invention may preferably be formulated asa liquid crystal composition capable of showingferroelectricity, particularly a liquid crystalcomposition showing a chiral smectic phase.
Specific examples of another mesomorphiccompound described above may include those denoted bythe following formulae (III) to (XII). ##STR4## wherein e denotes 0 or 1 and f denotes 0 or 1 withproviso that e+f=0 or 1; Y" denotes H, halogen,CH.sub.3 or CF.sub.3 ; and X.sub.1 ' and X.sub.2 ' respectively denote asingle bond, ##STR5## --O-- or ##STR6## X.sub.3 ' and X.sub.4 ' respectively denote a single bond, ##STR7## --OCH.sub.2 -- or --CH.sub.2 O--.
In the formula (III), preferred compoundsthereof may include those represented by the followingformulas (IIIa) to (IIIe): ##STR8## wherein g and h respectively denote 0 or 1 with provisothat g+h=0 or 1; i denotes 0 or 1; X.sub.1 ' and X.sub.2 ' respectively denote a single bond, ##STR9## --O-- or ##STR10## and X.sub.3 ', X.sub.4 ' and X.sub.5 ' respectively denote asingle bond, ##STR11## --CH.sub.2 O-- or --OCH.sub.2 --.
In the formula (IV), preferred compoundsthereof may include those represented by the followingformulas (IVa) to (IVc): ##STR12## wherein j denotes 0 or 1; Y.sub.1 ", Y.sub.2 " and Y.sub.3 " respectivelydenote H, halogen, CH.sub.3 or CF.sub.3 ; X.sub.1 ' and X.sub.2 ' respectivelydenote a single bond, ##STR13## --O-- and ##STR14## andX.sub.3 ' and X.sub.4 ' respectively denote a single bond, ##STR15## --CH.sub.2 O--, --OCH.sub.2 --, --CH.sub.2 CH.sub.2 --, ##STR16## or --O--.
In the formula (V), preferred compoundsthereof may include those represented by the followingformulas (Va) and (Vb): ##STR17## wherein k, l and m respectively denote 0 or 1 withproviso that k+l+m=0, 1 or 2; X.sub.1 ' and X.sub.2 ' respectively denote a single bond, ##STR18## --O-- or ##STR19## and X.sub.3 ' and X.sub.4 ' respectively denote a singlebond, ##STR20## --CH.sub.2 O or --OCH.sub.2 --.
In the formula (VI), preferred compoundsthereof may include those represented by the followingformulas (VIa) to (VIf): ##STR21##
Herein, R.sub.1 ' and R.sub.2 ' respectively denote alinear or branched alkyl group having 1-18 carbonatoms capable of including one or non-neighboring twoor more methylene groups which can be replaced with --CHhalogen- and capable of further including one or two ormore non-neighboring methylene groups other than thosedirectly connected to X.sub.1 ' or X.sub.2 ' which can be replacedwith at least one species of --O--, ##STR22## with proviso that R.sub.1 ' and R.sub.2 ' respectively do not connect to a ring structure by asingle bond when R.sub.1 ' and R.sub.2 ' respectively denote ahalogenated alkyl group containing one methylene groupreplaced with --CH halogen- or --CH(CF.sub.3)--.
Further, preferred examples of R.sub.1 ' and R.sub.2 ' mayrespectively include those represented by the followinggroups (i) to (ix):
i) a linear alkyl group having 1-15 carbonatoms;
ii) ##STR23##
wherein p denotes an integer of 0-5 and qdenotes an integer of 2-11 (optically active orinactive);
iii) ##STR24##
wherein r denotes an integer of 0-6, sdenotes 0 or 1, and t denotes all integer of 1-14 (optically active or inactive);
iv) ##STR25##
wherein u denotes 0 or 1 and v denotes aninteger of 1-16;
v) ##STR26##
wherein w denotes an integer of 1-15 (optically active or inactive);
vi) ##STR27##
wherein x denotes an integer of 0-2 and ydenotes an integer of 1-15;
vii) ##STR28##
wherein z denotes an integer of 1-15;
viii) ##STR29##
wherein A denotes an integer of 0-2 and Bdenotes an integer of 1-15 (optically active orinactive); and
ix) ##STR30##
wherein c denotes an integer of 0-2 and Ddenotes an integer of 1-15 (optically active orinactive).
In the above-mentioned formulas (IIIa) to(IIId), more preferred compounds thereof may includethose represented by the formulas (IIIaa) to (IIIdc): ##STR31##
In the above-mentioned formulas (IVa) to(IVc), more preferred compounds thereof may includethose represented by the formulas (IVaa) to (IVcb): ##STR32##
In the above-mentioned formulas (Va) and(Vb), more preferred compounds thereof may includethose represented by the formulas (Vaa) to (Vbf): ##STR33##
In the above-mentioned formulas (VIa) to(VIf), more preferred compounds thereof may includethose represented by the formulas (VIaa) to (VIfa): ##STR34## wherein E denotes 0 or 1; X.sub.1 ' and X.sub.2 ' respectivelydenote a single bond, ##STR35## --O-- or ##STR36## andX.sub.3 ' denotes a single bond, ##STR37## --CH.sub.2 O-- or--OCH.sub.2 --. ##STR38## wherein F and G respectively denote 0 or 1; X.sub.1 ' and X.sub.2 40 respectively denote a single bond, ##STR39## or --O--;and X.sub.3 ' and X.sub.4 ' respectively denote a single bond, ##STR40## --CH.sub.2 O-- or --OCH.sub.2 --.
In the above formula (VII), preferredcompounds thereof may include those represented by thefollowing formulas (VIIa) and (VIIb): ##STR41##
In the above formula (VIII), preferredcompounds thereof may include those represented by thefollowing formulas (VIIIa) and (VIIIb). ##STR42##
More preferred compounds of the formula(VIIIb) may include those represented by the formulas(VIIIba) to (VIIIbb): ##STR43## Herein, R.sub.3 ' and R.sub.4 ' respectively denote alinear or branched alkyl group having 1-18 carbonatoms capable of including one or non-neighboring twoor more methylene groups which can be replaced with --CHhalogen- and capable of further including one or two ormore non-neighboring methylene groups other than thosedirectly connected to X.sub.1 ' or X.sub.2 ' which can be replacedwith at least one species of --O--, ##STR44## with proviso that R.sub.3 ' and R.sub.4 ' respectively do not connect to a ring structure by asingle bond when R.sub.3 ' and R.sub.4 ' respectively denote ahalogenated alkyl group containing one methylene groupreplaced with --CH halogen-.
Further, preferred examples of R.sub.3 ' and R.sub.4 ' mayrespectively include those represented by the followinggroups (i) to (vii):
i) a linear alkyl group having 1-15 carbonatoms;
ii) ##STR45##
wherein p denotes an integer of 0-5 and qdenotes an integer of 2-11 (optically active orinactive);
iii) ##STR46##
wherein r denotes an integer of 0-6, sdenotes 0 or 1, and t denotes an integer of 1-14 (optically active or inactive);
iv) ##STR47##
wherein u denotes an integer of 0 or 1 and vdenotes an integer of 1-16 (optically active orinactive);
v) ##STR48##
wherein w denotes an integer of 1-15 (optically active or inactive);
vi) ##STR49##
wherein A denotes an integer of 0-2 and Bdenotes an integer of 1-15 (optically active orinactive); and
vii) ##STR50##
wherein C denotes an integer of 0-2 and Ddenotes an integer of 1-15 (optically active orinactive). ##STR51## wherein H and J respectively denote 0 or 1 with provisothat H+J=0 or 1; X.sub.1 ' and X.sub.2 ' respectively denote asingle bond, ##STR52## or --O--; A.sub.2 ' denotes ##STR53## and X.sub.3 ' and X.sub.4 ' respectively denote asingle bond, ##STR54## --CH.sub.2 O-- or --OCH.sub.2 --. ##STR55## wherein X.sub.1 ' and X.sub.2 ' respectively denote a single bond, ##STR56## or --O--; A.sub.3 ' denotes ##STR57## andX.sub.3 ' and X.sub.4 ' respectively denote a single bond, ##STR58## --CH.sub.2 O-- or --OCH.sub.2 --. ##STR59## wherein X.sub.1 ' and X.sub.2 ' respectively denote a single bond, ##STR60## or --O--; A.sub.4 ' denotes ##STR61## andX.sub.3 ' respectively denotes a single bond, ##STR62## --CH.sub.2 O-- or --OCH.sub.2 --. ##STR63## wherein K, L and M respectively denote 0 or 1 with theproviso that K+L+M=0 or 1; X.sub.1 ' denotes a single bond, ##STR64## or --O--; X.sub.3 ' denotes a single bond, ##STR65## --CH.sub.2 O-- or --OCH.sub.2 --; Y.sub.4 ", Y.sub.5 " and Y.sub.6 " respectivelydenote H or F; and Z.sub.1 ' is CH or N.
In the above formula (IX), preferred compoundsthereof may include those represented by the followingformulas (IXa) to (IXc): ##STR66##
In the above formula (X), preferred compoundsthereof may include those represented by the followingformulas (Xa) and (Xb): ##STR67##
In the above formula (XII), preferredcompounds thereof may include those represented by thefollowing formulas (XIIa) and (XIId): ##STR68##
In the above-mentioned formulas (IXa) to(IXc), more preferred compounds thereof may includethose represented by the formulas (IXaa) to (IXcc): ##STR69##
In the above-mentioned formulas (Xa) to (Xb),more preferred compounds thereof may include thoserepresented by the formulas (Xaa) to (Xbb): ##STR70##
In the above formula (XI), preferredcompounds thereof may include those represented by thefollowing formulas (XIa) to (XIg): ##STR71##
In the above-mentioned formulas (XIIa) to(XIId), more preferred compounds thereof may includethose represented by the formula (XIIaa) to (XIIdb): ##STR72##
Herein, R.sub.5 ' and R.sub.6 ' respectively denote alinear or branched alkyl group having 1-18 carbonatoms capable of including one non-neighboring two ormore methylene groups other than those directlyconnected to X.sub.1 ' or X.sub.2 ' which can be replaced with atleast one species of --O--, ##STR73##
Further, preferred examples of R.sub.5 ' and R.sub.6 ' mayrespectively include those represented by the followinggroups (i) to (vi):
i) a linear alkyl group having 1-15 carbonatoms;
ii) ##STR74##
wherein p denotes an integer of 0-5 and qdenotes an integer of 2-11 (optically active orinactive);
iii) ##STR75##
wherein r denotes an integer of 0-6, sdenotes 0 or 1, and t denotes an integer of 1-14 (optically active or inactive);
iv) ##STR76##
wherein w denotes an integer of 1-15 (optically active or inactive);
v) ##STR77##
wherein A denotes an integer of 0-2 and Bdenotes an integer of 1-15 (optically active orinactive); and
vi) ##STR78##
wherein C denotes an integer of 0-2 and Ddenotes an integer of 1-15 (optically active orinactive).
Specific examples of another mesomorphiccompound may also include those represented by thefollowing formulae (XIII) to (XVII). ##STR79##
Herein, R.sub.7 ' and R.sub.8 ' respectively denotehydrogen or a linear or branched alkyl group having 1-18 carbon atoms capable of including one non-neighboringtwo or more methylene groups other thanthose directly connected to X.sub.6 ' or X.sub.9 ' which can bereplaced with at least one species of --O--, ##STR80##
Further, preferred examples of R.sub.7 ' and R.sub.8 ' mayrespectively include those represented by the followinggroups (i) to (vii):
i) a linear alkyl group having 1-15 carbonatoms;
ii) ##STR81##
wherein p denotes an integer of 0-5 and qdenotes an integer of 2-11 (optically active orinactive);
iii) ##STR82##
wherein r denotes an integer of 0-6, sdenotes 0 or 1, and t denotes an integer of 1-14 (optically active or inactive);
iv) ##STR83##
wherein w denotes an integer of 1-15 (optically active or inactive);
v) ##STR84##
wherein A denotes an integer of 0-2 and Bdenotes an integer of 1-15 (optically active orinactive);
vi) ##STR85##
wherein C denotes an integer of 0-2 and Ddenotes an integer of 1-15 (optically active orinactive); and
vii) H (hydrogen).
In the above formulae (XIII) to (XVII); N, Q,R and T are 0 or 1; Y.sub.7 ", Y.sub.8 " and Y.sub.9 " are H or F; X.sub.6 ' and X.sub.7 ' respectively denote a .single bond, --CO--O--,--O--CO-- or --O--; X.sub.7 ' and X.sub.8 ' respectively denote asingle bond, --CO--O--, --O--CO--, --CH.sub.2 O-- or --OCH.sub.2 --; Z.sub.2 ' is--O-- or --S--; and A.sub.4 ' is ##STR86##
The compound of the formula (XIII) maypreferably include a compound represented by thefollowing formula (XIIIa): ##STR87##
The compound of the formula (XVI) maypreferably include compounds represented by thefollowing formulae (XVIa) and (XVIb): ##STR88##
The compound of the formula (XVII) maypreferably include compounds represented by thefollowing formulae (XVIIa) to (XVIIe): ##STR89##
The compounds of the formulae (XVIa) and(XVIb) may preferably include compounds represented bythe following formulae (XVIaa) to (XVIbc): ##STR90##
In formulating the liquid crystal compositionaccording to the present invention, the liquid crystalcomposition may desirably contain 1-80 wt. %,preferably 1-60 wt. %, more preferably 1-40 wt. %of a quinoxaline compound represented by the formula(I).
Further, when two or more species of thequinoxaline compounds represented by the formula (I)are used, the liquid crystal composition may desirablycontain 1-80 wt. %, preferably 1-60 wt. %, morepreferably 1-40 wt. %, of the two or more species ofthe quinoxaline compounds represented by the formula(I).
The liquid crystal device according to thepresent invention may preferably be prepared by heatingthe liquid crystal composition prepared as describedabove into an isotropic liquid under vacuum, filling ablank cell comprising a pair of oppositely spacedelectrode plates with the composition, graduallycooling the cell to form a liquid crystal layer andrestoring the normal pressure.
FIG. 1 is a schematic sectional view of anembodiment of the liquid crystal device utilizingferroelectricity prepared as described above forexplanation of the structure thereof.
Referring to FIG. 1, the liquid crystaldevice includes a liquid crystal layer 1 assuming achiral smectic phase disposed between a pair of glasssubstrates 2 each having thereon a transparentelectrode 3 and an insulating alignment control layer4. The glass substrates 2 are placed or arrangedopposite each other. Lead wires 6 are connected tothe electrodes so as to apply a driving voltage to theliquid crystal layer 1 from a power supply 7. Outsidethe substrates 2, a pair of polarizers 8 are disposedso as to modulate incident light I.sub.0 from a lightsource 9 in cooperation with the liquid crystal 1 toprovide modulated light I.
Each of two glass substrates 2 is coated witha transparent electrode 3 comprising a film of In.sub.2 O.sub.3,SnO.sub.2 or ITO (indium-tin-oxide) to form an electrodeplate. Further thereon, an insulating alignment controllayer 4 is formed by rubbing a film of a polymer suchas polyimide with gauze or acetate fiber-planted clothso as to align the liquid crystal molecules in therubbing direction. Further, it is also possible tocompose the alignment control layer of two layers,e.g., by first forming an insulating layer of aninorganic material, such as silicon nitride, siliconcarbide containing hydrogen, silicon oxide, boronnitride, boron nitride containing hydrogen, ceriumoxide, aluminum oxide, zirconium oxide, titanium oxide,or magnesium fluoride, and forming thereon an alignmentcontrol layer of an organic insulating material, suchas polyvinyl alcohol, polyimide, polyamide-imide,polyester-imide, polyparaxylylene, polyester,polycarbonate, polyvinyl acetal, polyvinyl chloride,polyvinyl acetate, polyamide, polystyrene, celluloseresin, melamine resin, urea resin, acrylic resin, orphotoresist resin. Alternatively, it is also possibleto use a single layer of inorganic insulating alignmentcontrol layer comprising the above-mentioned inorganicmaterial or organic insulating alignment control layercomprising the above-mentioned organic material. Aninorganic insulating alignment control layer may beformed by vapor deposition, while an organicinsulating alignment control layer may be formed byapplying a solution of an organic insulating materialor a precursor thereof in a concentration of 0.1 to 20 wt. %, preferably 0.2-10 wt. %, by spinner coating,dip coating, screen printing, spray coating or rollercoating, followed by curing or hardening underprescribed hardening condition (e.g., by heating).The insulating alignment control layer 4 may have athickness of ordinarily 10 .ANG.-1 micron, preferably 10-3000 .ANG., further preferably 10-1000 .ANG.. The twoglass substrates 2 with transparent electrodes 3(which may be inclusively referred to herein as"electrode plates") and further with insulatingalignment control layers 4 thereof are held to have aprescribed (but arbitrary) gap with a spacer 5. Forexample, such a cell structure with a prescribed gapmay be formed by sandwiching spacers of silica beadsor alumina beads having a prescribed diameter with twoglass plates, and then sealing the periphery thereofwith, a sealing material comprising, e.g., an epoxyadhesive. Alternatively, a polymer film or glassfiber may also be used as a spacer. Between the twoglass plates, a liquid crystal composition assuming achiral smectic phase is sealed up to provide a liquidcrystal layer 1 in a thickness of generally 0.5 to 20 .mu.m, preferably 1 to 5 .mu.m.
The transparent electrodes 3 are connected tothe external power supply 7 through the lead wires 6.Further, outside the glass substrates 2, polarizers 8are applied. The device shown in FIG. 1 is of atransmission type and is provided with a light source9.
FIG. 2 is a schematic illustration of aliquid crystal cell (device) utilizing ferroelectricityfor explaining operation thereof. Reference numerals21a and 21b denote substrates (glass plates) on which atransparent electrode of, e.g., In.sub.2 O.sub.3, SnO.sub.2, ITO(indium-tin-oxide), etc., is disposed, respectively. Aliquid crystal of an SmC*-phase (chiral smectic Cphase) or SmH*-phase (chiral smectic H phase) in whichliquid crystal molecular layers 22 are alignedperpendicular to surfaces of the glass plates ishermetically disposed therebetween. Lines 23 showliquid crystal molecules. Each liquid crystalmolecule 23 has a dipole moment (P.perp.) 24 in a directionperpendicular to the axis thereof. The liquid crystalmolecules 23 continuously form a helical structure inthe direction of extension of the substrates. When avoltage higher than a certain threshold level isapplied between electrodes formed on the substrates21a and 21b, a helical structure of the liquid crystalmolecule 23 is unwound or released to change thealignment direction of respective liquid crystalmolecules 23 so that the dipole moments (P.perp.) 24 areall directed in the direction of the electric field.The liquid crystal molecules 23 have an elongatedshape and show refractive anisotropy between the longaxis and the short axis thereof. Accordingly, it iseasily understood that when, for instance, polarizersarranged in a cross nicol relationship, i.e., withtheir polarizing directions crossing each other, aredisposed on the upper and the lower surfaces of theglass plates, the liquid crystal cell thus arrangedfunctions as a liquid crystal optical modulationdevice of which optical characteristics vary dependingupon the polarity of an applied voltage.
Further, when the liquid crystal cell is madesufficiently thin (e.g., less than about 10 microns), thehelical structure of the liquid crystal molecules isunwound to provide a non-helical structure even in theabsence of an electric field, whereby the dipole momentassumes either of the two states, i.e., Pa in an upperdirection 34a or Pb in a lower direction 34b as shownin FIG. 3, thus providing a bistable condition. Whenan electric field Ea or Eb higher than a certainthreshold level and different from each other inpolarity as shown in FIG. 3 is applied to a cellhaving the above-mentioned characteristics by usingvoltage application means 31a and 31b, the dipolemoment is directed either in the upper direction 34a orin the lower direction 34b depending on the vector ofthe electric field Ea or Eb. In correspondence withthis, the liquid crystal molecules are oriented ineither of a first stable state 33a and a second stablestate 33b.
When the above-mentioned ferroelectric liquidcrystal is used as an optical modulation element, it ispossible to obtain two advantages. First is that theresponse speed is quite fast. Second is that theorientation of the liquid crystal shows bistability.The second advantage will be further explained, e.g.,with reference to FIG. 3. When the electric field Eais applied to the liquid crystal molecules, they areoriented in the first stable state 33a. This state isstably retained even if the electric field is removed.On the other hand, when the electric field Eb of whichdirection is opposite to that of the electric field Eais applied thereto, the liquid crystal molecules areoriented to the second stable state 33b, whereby thedirections of molecules are changed. This state issimilarly stably retained even if the electric field isremoved. Further, as long as the magnitude of theelectric field Ea or Eb being applied is not above acertain threshold value, the liquid crystal moleculesare placed in the respective orientation states.
FIGS. 5A and 5B are waveform diagramsshowing driving voltage waveforms adopted in driving aferroelectric liquid crystal panel as an embodiment ofthe liquid crystal device according to the presentinvention.
Referring to FIG. 5A, at S.sub.S is shown aselection scanning signal waveform applied to aselected scanning line, at S.sub.N is shown a non-selectionscanning signal waveform applied to a non-selectedscanning line, at I.sub.S is shown a selection data signalwaveform (providing a black display state) applied toa selected data line, and at I.sub.N is shown a non-selectiondata signal waveform (providing a whitedisplay state) applied to a non-selected data line.Further, at (I.sub.S -S.sub.S) and (I.sub.N -S.sub.S) in the figure areshown voltage waveforms applied to pixels on aselected scanning line, whereby a pixel supplied withthe voltage (I.sub.S -S.sub.S) assumes a black display state anda pixel supplied with the voltage (I.sub.N -S.sub.S) assumes awhite display state. FIG. 5B shows a time-serialwaveform used for providing a display state as shownin FIG. 6.
In the driving embodiment shown in FIGS. 5Aand 5B, a minimum duration .DELTA.t of a single polarityvoltage applied to a pixel on a selected scanning linecorresponds to the period of a writing phase t.sub.2, andthe period of a one-line clearing phase t.sub.1 is set to2.DELTA.t.
The parameters V.sub.S, V.sub.I and .DELTA.t in the drivingwaveforms shown in FIGS. 5A and 5B are determineddepending on switching characteristics of aferroelectric liquid crystal material used. In thisembodiment, the parameters are fixed at a constantvalue of a bias ratio V.sub.I /(V.sub.I +V.sub.S)=1/3 .times.. It is ofcourse possible to increase a range of a drivingvoltage allowing an appropriate matrix drive byincreasing the bias ratio. However, a large biasratio corresponds to a large amplitude of a datasignal and leads to an increase in flickering and alower contrast, thus being undesirable in respect ofimage quality. According to our study, a bias ratioof about 1/3-1/4 was practical.
Based on an arrangement appearing hereinbelowand data format comprising image data accompanied withscanning line address data and by adoptingcommunication synchronization Using a SYNC signal asshown in FIGS. 7 and 8, there is provided a liquidcrystal display apparatus of the present inventionwhich uses the liquid crystal device according to thepresent invention as a display panel portion.
Referring to FIG. 7, the ferroelectricliquid crystal display apparatus 101 includes a graphiccontroller 102, a display panel 103, a scanning linedrive circuit 104, a data line drive circuit 105, adecoder 106, a scanning signal generator 107, a shiftresistor 108, a line memory 109, a data signalgenerator 110, a drive control circuit 111, a graphiccentral processing unit (GCPU) 112, a host centralprocessing unit (host CPU) 113, and an image datastorage memory (VRAM) 114.
Image data are generated in the graphiccontroller 102 in an apparatus body and transferred toa display panel 103 by signal transfer means. Thegraphic controller 102 principally comprises a CPU(central processing unit, hereinafter referred to as"GCPU") 112 and a VRAM (video-RAM, image data storagememory) 114 and is in charge of management andcommunication of image data between a host CPU 113 andthe liquid crystal display apparatus (FLCD) 101. Thecontrol of the display apparatus is principallyrealized in the graphic controller 102. A lightsource is disposed at the back of the display panel103.
Hereinbelow, the present invention will beexplained more specifically width reference to examples.It is however to be understood that the presentinvention is not restricted to these examples.
EXAMPLE 1
Production of quinoxaline compounds (Examplecompounds Nos. I-23 and I-57)
Step i) ##STR91##
In a 100 ml-round-bottomed flask, 10,00 g(67.0 mM) of 4-butylaniline was placed. Understirring at room temperature, 6.7 ml (70.8 mM) ofacetic anhydride was gradually added thereto, followedby stirring for 10 minutes at room temperature andfurther by stirring for 30 minutes under heat-refluxing.After the reaction, the reaction mixturewas cooled to room temperature and poured into waterto precipitate a crystal. The crystal was recoveredby filtration and washed with water, followed byrecrystallization from a methanol-water mixturesolvent to obtain 10.83 g of 4-butylacetanilide(Yield: 84.5%).
To 10.20 g (52.3 mM) of 4-butylacetanilide,20 ml of 78%-sulfuric acid was gradually addeddropwise under stirring on an ice bath. After theaddition, the ice bath was removed and a mixture ofsulfuric acid and nitric acid (prepared by adding 7 mlof nitric acid to 7 ml of sulfuric acid under stirringon an ice bath) was added to the above mixture,followed by stirring for 40 minutes under roomtemperature. After the reaction, the reaction mixturewas poured into about 200 ml of ice water toprecipitate a crystal. The crystal was recovered byfiltration and washed with water, followed byrecrystallization from an ethanol-water mixturesolvent to obtain 10.20 g of 4-butyl-2-nitroacetanilide(Yield: 82.6%).
In a 500 ml-round-bottomed flask, 10.0 g(42.3 mM) of 4-butyl-2-nitroacetanilide and 180 ml ofethanol were mixed. To the solution, 40 ml of 10%-sodiumhydroxide aqueous solution was added, followedby stirring for 30 minutes under heat-refluxing.After the reaction, the organic solvent was distilledoff and an appropriate amount of water was added tothe residue, followed by extraction with ethylacetate. The organic layer was washed with water anddried with milabilite, followed by concentration underreduced pressure to obtain 8.20 g of red oily 4-butyl-2-nitroaniline(Yield: 99.7%).
1.11 g (5.15 mM) of 4-butyl-2-nitroaniline, 5 ml of methanol, 0.35 g of activated carbon and 0.04 gof ferric chloride hexahydrate were placed in a 50 ml-three-neckedflask and kept at about 60.degree. C. To themixture, 1.5 ml (24.7 mM) of hydrazine hydrate wasgradually added dropwise, followed by stirring for 2 hours under heat refluxing. After the reaction, thereaction mixture was subjected to filtration by meansof suction under heating to remove the activatedcarbon. The filtrate was concentrated under reducedpressure and an appropriate amount of water was addedthereto. The mixture was subjected to extraction withethyl acetate. The organic layer was washed withwater and dried with milabilite, followed byconcentration under reduced pressure to obtain a crudeproduct. To the crude product (residue), anappropriate amount of hexane was added, followed bycooling on an ice bath to precipitate a crystal. Thecrystal was recovered by filtration to obtain 0.82 gof 4-butyl-1,2-phenylenediamine (Yield: 87.4%).
Step ii) ##STR92##
334 g (2.46M) of 4-hydroxyacetophenone, 489 g (2.21M) of decylbromide, 94.5 g (2.21M) of sodiumhydroxide and 2.2 liters of N,N-dimethylformamide wereplaced in a 5 liter-three-necked flask, followed bystirring for 3 hours under heat-refluxing. Aftercooling, the reaction mixture was poured into 4 litersof water and subjected to extraction with isopropylether. The organic layer was successively washed withwater, 5%-sodium hydroxide aqueous solution, andwater and dried with milabilite, followed byconcentration under reduced pressure to obtain 581 gof pale yellow oily 4-decyloxyacetophenone (Yield:95.3%).
268 g (2.42M) of selenium dioxide, 1.5 liters of dioxane and 73 ml of water were placed in a5 liter-three-necked flask, followed by heating at 80.degree. C. To the solution, 590 g (2.14M) of 4-decyloxyacetophenonewas added, followed by stirringfor 19 hours under heat-refluxing. After cooling, theinsoluble matter was removed by filtration and thefiltrate was concentrated under reduced pressure. Tothe concentrated filtrate, 6 liters of water wasadded, followed by stirring for 16 hours under heatrefluxing. After cooling, the resultant precipitatedcrystal was recovered by filtration and recystallizedfrom an acetone-water mixture solvent to obtain 570 gof 4-decyloxyphenylglyoxal monohydrate (Yield: 86.5%.
Step iii) ##STR93##
0.40 g (2.44 mM) of 4-butyl-1,2-phenylenediamine,0.75 g (2.43 mM) of 4-decyloxyphenylglyoxalmonohydrate, and 15 ml of ethanol were placed in a 50 ml-round-bottomed flask, followed by stirring for 20 minutes under heat refluxing. After the reaction, thereaction mixture was cooled on an ice bath toprecipitate a crystal. The crystal was recovered byfiltration and purified by silica gel columnchromatography (eluent toluene/ethyl acetate=100/8)to obtain: 6-butyl-2-(4-decyloxyphenyl)-quinoxaline(Ex. Comp. No. I-23) and 7-butyl-2-(4-decyloxyphenyl)quinoxaline(Ex. Comp. No. I-57).
These quinoxaline compounds respectivelyshowed the following phase transition series (.degree.C.). ##STR94##
Herein, the respective symbols denote thefollowing phase; Iso: isotropic phase; N: nematicphase; SmA: smectic A phase; SmC: smectic C phase;Sm3: smectic phase other than SmA and SmC; and Cryst.:crystal.
EXAMPLE 2
A liquid crystal composition A was preparedby mixing the following compounds in the
__________________________________________________________________________Structural formula wt. parts__________________________________________________________________________ ##STR95## 6 ##STR96## 6 ##STR97## 7 ##STR98## 14 ##STR99## 8 ##STR100## 4 ##STR101## 2 ##STR102## 10 ##STR103## 5 ##STR104## 10 ##STR105## 7 ##STR106## 7 ##STR107## 5 ##STR108## 2 ##STR109## 2 ##STR110## 2 ##STR111## 3__________________________________________________________________________
The liquid crystal composition A was furthermixed with the following example compounds in theindicated proportions to provide a liquid crystalcomposition
__________________________________________________________________________Ex. Comp. No. Structural formula wt. parts__________________________________________________________________________1-2 ##STR112## 5I-100 ##STR113## 2I-112 ##STR114## 2 Composition A 91__________________________________________________________________________
Two 0.7 mm-thick glass plates were providedand respectively coated with an ITO film to form anelectrode for voltage application, which was furthercoated with an insulating layer of vapor-depositedSiO.sub.2. On the insulating layer, a 0.2%-solution ofsilane coupling agent (KBM-602, available fromShinetsu Kagaku K.K.) in isopropyl alcohol was appliedby spinner coating at a speed of 2000 rpm for 15 second and subjected to hot curing treatment at 120.degree. C.for 20 min.
Further, each glass plate provided with anITO film and treated in the above described manner wascoated with a 1.5%-solution of polyimide resinprecursor (SP-510, available from Toray K.K.) indimethylacetoamide by a spinnear coater rotating at2000 rpm for 15 seconds. Thereafter, the coating filmwas subjected to heat curing at 300.degree. C. for 60 min. toobtain about 250 .ANG.-thick film. The coating film wasrubbed with acetate fiber-planted cloth. The thustreated two glass plates were washed with isopropylalcohol. After silica beads with an average particlesize of 2.0 microns were dispersed on one of the glassplates, the two glass plates were applied to eachother with a bonding sealing agent (Lixon Bond,available from Chisso K.K.) so that their rubbeddirections were parallel to each other and heated at100.degree. C. for 60 min. to form a blank cell. The cell gapwas found to be about 2 microns as measured by a Berekcompensator.
Then, the liquid crystal composition Bprepared above was heated into an isotropic liquid,and injected into the above prepared cell under vacuumand, after sealing, was gradually cooled to 25.degree. C. at arate of 20.degree. C./hour to prepare a ferroelectric liquidcrystal device.
The ferroelectric liquid crystal device wassubjected to measurement of an optical response time(time from voltage application until the transmittancechange reaches 90% of the maximum under theapplication of a peak-to-peak voltage Vpp of 20 V incombination with right-angle cross-nicol polarizers)and observation of switching states. In the device, amonodomain with a good and uniform alignmentcharacteristic was observed. The results of themeasurement of response time are shown
______________________________________ 10.degree. C. 25.degree. C. 40.degree. C.______________________________________Response time (.mu.sec) 575 302 168______________________________________
Comparative Example 1
A ferroelectric liquid crystal device wasprepared and subjected to measurement of response timein the same manner as in Example 2 except forinjecting the composition A alone into a blank cell,whereby the following results were
______________________________________ 10.degree. C. 25.degree. C. 40.degree. C.______________________________________Response time (.mu.sec) 668 340 182______________________________________
EXAMPLE 3
A liquid crystal composition C was preparedby mixing the following Example Compounds instead ofthose of (I-2), (I-100) and (I-112) used in Example2 in the indicated proportions with the liquidcrystal composition
______________________________________Ex.Comp. wt.No. Structural formula parts______________________________________I-34 ##STR115## 4I-58 ##STR116## 2I-83 ##STR117## 2 Composition A 92______________________________________
A ferroelectric liquid crystal device wasprepared in the same manner as in Example 2 exceptthat the above liquid crystal composition C was used,and the device was subjected to measurement of opticalresponse time and observation of switching states. Inthe device, a monodomain with a good and uniformalignment characteristic was observed. The results ofthe measurement are shown
______________________________________ 10.degree. C. 25.degree. C. 40.degree. C.______________________________________Response time (.mu.sec) 533 275 152______________________________________
EXAMPLE 4
A liquid crystal composition D was preparedby mixing the following compounds in the
__________________________________________________________________________Structural formula wt. parts__________________________________________________________________________ ##STR118## 12 ##STR119## 10 ##STR120## 10 ##STR121## 3 ##STR122## 8 ##STR123## 4 ##STR124## 6 ##STR125## 2 ##STR126## 8 ##STR127## 15 ##STR128## 7 ##STR129## 7 ##STR130## 4 ##STR131## 2 ##STR132## 2__________________________________________________________________________
The liquid crystal composition D was furthermixed with the following compounds in the proportionsindicated below to provide a liquid crystalcomposition
__________________________________________________________________________Ex. Comp. No. Structural Formula wt. parts__________________________________________________________________________I-9 ##STR133## 5I-111 ##STR134## 2I-121 ##STR135## 3 Composition D 90__________________________________________________________________________
A ferroelectric liquid crystal device wasprepared in the same manner as in Example 2 exceptthat the above liquid crystal composition E was used,and the device was subjected to measurement of opticalresponse time. The results are shown
______________________________________ 10.degree. C. 25.degree. C. 40.degree. C.______________________________________Response time (.mu.sec) 632 310 175______________________________________
Comparative Example 2
A ferroelectric liquid crystal device wasprepared and subjected to measurement of response timein the same manner as in Example 2 except forinjecting the composition D alone used in Example 4 into a blank cell, whereby the following results
______________________________________ 10.degree. C. 25.degree. C. 40.degree. C.______________________________________Response time (.mu.sec) 784 373 197______________________________________
EXAMPLE 5
A liquid crystal composition F was preparedby mixing the following Example Compounds instead ofthose of (I-9), (I-111) and (I-121) used in Example4 in the indicated proportions with the liquidcrystal composition
__________________________________________________________________________Ex. Comp. No. Structural formula wt. parts__________________________________________________________________________I-96 ##STR136## 4I-116 ##STR137## 2I-160 ##STR138## 3 Composition D 90__________________________________________________________________________
A ferroelectric liquid crystal device wasprepared in the same manner as in Example 2 exceptthat the above liquid crystal composition F was used,and the device was subjected to measurement of opticalresponse time. The results are shown
______________________________________ 10.degree. C. 25.degree. C. 40.degree. C.______________________________________Response time (.mu.sec) 596 293 162______________________________________
EXAMPLE 6
A liquid crystal composition G was preparedby mixing the following compounds in the
__________________________________________________________________________Structural formula wt. parts__________________________________________________________________________ ##STR139## 10 ##STR140## 5 ##STR141## 7 ##STR142## 7 ##STR143## 6 ##STR144## 5 ##STR145## 5 ##STR146## 8 ##STR147## 8 ##STR148## 20 ##STR149## 5 ##STR150## 5 ##STR151## 6 ##STR152## 3__________________________________________________________________________
The liquid crystal composition G was furthermixed with the following compounds in the proportionsindicated below to provide a liquid crystalcomposition
__________________________________________________________________________Ex. Comp. No. Structural formula wt. parts__________________________________________________________________________I-45 ##STR153## 4I-127 ##STR154## 4I-168 ##STR155## 2 Composition G 90__________________________________________________________________________
A ferroelectric liquid crystal device wasprepared in the same manner as in Example 2 exceptthat the above liquid crystal composition H was used,and the device was subjected to measurement of opticalresponse time and observation of switching states. Inthe device, a monodomain with a good and uniformalignment characteristic was observed. The results ofthe measurement are shown
______________________________________ 10.degree. C. 25.degree. C. 40.degree. C.______________________________________Response time (.mu.sec) 508 259 140______________________________________
Further, when the device was driven, a clearswitching action was observed, and good bistabilitywas shown after the termination of the voltageapplication.
Comparative Example 3
A ferroelectric liquid crystal device wasprepared and subjected to measurement of response timein the same manner as in Example 2 except forinjecting the composition G alone used in Example 6 into the cell, whereby the following results
______________________________________ 10.degree. C. 25.degree. C. 40.degree. C.______________________________________Response time (.mu.sec) 653 317 159______________________________________
EXAMPLE 7
A liquid crystal composition J was preparedby mixing the following Example Compounds instead ofthose of (I-45), (I-127) and (I-168) used in Example6 in the indicated proportions with the liquidcrystal composition
__________________________________________________________________________Ex. Comp. No. Structural formula wt. parts__________________________________________________________________________I-63 ##STR156## 4I-81 ##STR157## 4 I-132 ##STR158## 2 Composition G 90__________________________________________________________________________
A ferroelectric liquid crystal device wasprepared in the same manner as in Example 2 exceptthat the above liquid crystal composition J was used,and the device was subjected to measurement of opticalresponse time and observation of switching states. Inthe device, a monodomain with a good and uniformalignment characteristic was observed. The results ofthe measurement are shown
______________________________________ 10.degree. C. 25.degree. C. 40.degree. C.______________________________________Response time (.mu.sec) 493 243 135______________________________________
EXAMPLE 8
A liquid crystal composition k was preparedby mixing the following Example Compounds instead ofthose of (I-63), (I-81) and (I-132) used in Example 7 in the indicated proportions with the liquid crystalcomposition
__________________________________________________________________________Ex. Comp. No. Structural formula wt. parts__________________________________________________________________________I-27 ##STR159## 3I-67 ##STR160## 5I-88 ##STR161## 2 Composition G 90__________________________________________________________________________
A ferroelectric liquid crystal device wasprepared in the same manner as in Example 2 exceptthat the above liquid crystal composition K was used,and the device was subjected to measurement of opticalresponse time and observation of switching states. Inthe device, a monodomain with a good and uniformalignment characteristic was observed. The results ofthe measurement are shown
______________________________________ 10.degree. C. 25.degree. C. 40.degree. C.______________________________________Response time (.mu.sec) 465 231 123______________________________________
As apparent from the above Examples 2 to 8, the ferroelectric liquid crystal device including theliquid crystal compositions B, C, E, F, H, J and K,i.e., compositions containing a quinoxaline compoundaccording to the present invention, provided improvedoperation characteristic at a lower temperature, highspeed responsiveness and a decreased temperaturedependence of response speed.
EXAMPLE 9
A blank cell was prepared in the same manneras in Example 2 by using a 2% aqueous solution ofpolyvinyl alcohol resin (PVA-117, available fromKuraray K.K.) instead of the 1.5%-solution ofpolyimide resin precursor in dimethylacetoamide oneach electrode plate. A ferroelectric liquid crystaldevice was prepared by filling the blank cell with theliquid crystal composition F used in Example 5. Theliquid crystal device was subjected to measurementresponse time in the same manner as in Example 2. Theresults are shown
______________________________________ 10.degree. C. 25.degree. C. 40.degree. C.______________________________________Response time (.mu.sec) 585 293 168______________________________________
EXAMPLE 10
A blank cell was prepared in the same manneras in Example 2 except for omitting the SiO.sub.2 layer toform an alignment control layer composed of thepolyimide resin layer alone on each electrode plate.A ferroelectric liquid crystal devices were preparedby filling such a blank cell with liquid crystalcomposition F used in Example 5. The liquid crystaldevice was subjected to measurement of response timein the same manner as in Example 2. The results areshown
______________________________________ 10.degree. C. 25.degree. C. 40.degree. C.______________________________________Response time (.mu.sec) 566 278 152______________________________________
As is apparent from the above Examples 9 and10, also in the case of a different device structure,the device containing the ferroelectric liquid crystalcomposition F according to the present inventionprovided an improved low-temperature operationcharacteristic and a decreased temperature dependenceof response speed similarly as in Example 5.
EXAMPLE 11
A liquid crystal composition L was preparedby mixing the following compounds in the
__________________________________________________________________________Structural formula wt. parts__________________________________________________________________________ ##STR162## 5 ##STR163## 10 ##STR164## 5 ##STR165## 10 ##STR166## 7 ##STR167## 15 ##STR168## 5 ##STR169## 5 ##STR170## 5 ##STR171## 2 ##STR172## 5 ##STR173## 2 ##STR174## 6 ##STR175## 2 ##STR176## 3 ##STR177## 3 ##STR178## 10__________________________________________________________________________
The liquid crystal composition L was furthermixed with the following example compounds in theindicated proportions to provide a liquid crystalcomposition
__________________________________________________________________________Ex. Comp. No. Structural formula wt. parts__________________________________________________________________________I-4 ##STR179## 3I-31 ##STR180## 5I-89 ##STR181## 2 Composition L 90__________________________________________________________________________
Two 0.7 mm-thick glass plates were providedand respectively coated with an ITO film to form anelectrode for voltage application, which was furthercoated with an insulating layer of vapor-depositedSiO.sub.2. On the insulating layer, a 0.2%-solution ofsilane coupling agent (KBM-602, available fromShinetsu Kagaku K.K.) in isoprcpyl alcohol was appliedby spinner coating at a speed of 2000 rpm for 15 second and subjected to hot curing treatment at 120.degree. C.for 20 min.
Further, each glass plate provided with anITO film and treated in the above described manner wascoated with a 1.0%-solution of polyimide resinprecursor (SP-510, available from Toray K.K.) indimethylacetoamide by a spinner coater rotating at2000 rpm for 15 seconds. Thereafter, the coating filmwas subjected to heat curing at 300.degree. C. for 60 min. toobtain about 120 .ANG.-thick film. The coating film wasrubbed with acetate fiber-planted cloth. The thustreated two glass plates were washed with isopropylalcohol. After silica beads with an average particlesize of 1.5 microns were dispersed on one of the glassplates, the two glass plates were applied to eachother with a bonding sealing agent (Lixon Bond,available from Chisso K.K.) so that their rubbeddirections were parallel to each other and heated at100.degree. C. for 60 min. to form a blank cell. The cell gapwas found to be about 1.5 microns as measured by aBerek compensator.
Then, the liquid crystal composition Mprepared above was heated into an isotropic liquid,and injected into the above prepared cell under vacuumand, after sealing, was gradually cooled to 25.degree. C. at arate of 20.degree. C./hour to prepare a ferroelectric liquidcrystal device.
The ferroelectric liquid crystal device wassubjected to measurement of a contrast ratio at 30.degree. C.when the device was driven by applying a drivingvoltage waveform shown in FIGS. 5A and 5B (biasratio=1/3), whereby a contrast ratio of 25.2 wasobtained.
Comparative Example 4
A ferroelectric liquid crystal device wasprepared and subjected to measurement of a contrastratio in the same manner as in Example 11 except forinjecting the composition L alone used in Example 11 into a blank cell, whereby a contrast ratio of 6.7 wasobtained.
EXAMPLE 12
A liquid crystal composition N was preparedby mixing the following Example Compounds instead ofthose of (I-4), (I-31) and (I-89) used in Example11 in the indicated proportions with the liquidcrystal composition
______________________________________Ex.Comp. wt.No. Structural formula parts______________________________________I-56 2 ##STR182##I-65 6 ##STR183##I-93 2 ##STR184##Composition L 90______________________________________
A ferroelectric liquid crystal device wasprepared in the same manner as in Example 11 exceptthat the above liquid crystal composition N was used,and the device was subjected to measurement of acontrast ratio, whereby a contrast ratio of 23.1 wasobtained.
EXAMPLE 13
A liquid crystal composition P was preparedby mixing the following Example Compounds instead ofthose of (I-56), (I-65) and (I-93) used in Example12 in the indicated proportions with the liquidcrystal composition
______________________________________Ex.Comp. wt.No. Structural formula parts______________________________________I-17 5 ##STR185##I-87 2 ##STR186## I-140 3 ##STR187##Composition L 90______________________________________
A ferroelectric liquid crystal device wasprepared in the same manner as in Example 11 exceptthat the above liquid crystal composition P was used,and the device was subjected to measurement of acontrast ratio, whereby a contrast ratio of 18.5 wasobtained.
As apparent from the above Examples 11 to 13, the ferroelectric liquid crystal device including theliquid crystal compositions M, N and P, i.e.,compositions containing a quinoxaline compoundaccording to the present invention, provided improveda higher contrast ratio when driven.
EXAMPLE 14
A blank cell was prepared in the same manneras in Example 11 by using a 2% aqueous solution ofpolyvinyl alcohol resin (PVA-117, available fromKuraray K.K.) instead of the 1.0%-solution ofpolyimide resin precursor in dimethylacetoamide oneach electrode plate. A ferroelectric liquid crystaldevice was prepared by filling the blank cell with theliquid crystal composition N used in Example 12. Theliquid crystal device was subjected to measurementa contrast ratio in the same manner as in Example 11, whereby a contrast ratio of 27.5 was obtained.
EXAMPLE 15
A blank cell was prepared in the same manneras in Example 11 except for omitting the SiO.sub.2 layer toform an alignment control layer composed of thepolyimide resin layer alone on each electrode plate.A ferroelectric liquid crystal devices were preparedby filling such a blank cell with liquid crystalcomposition N used in Example 12. The liquid crystaldevice was subjected to measurement of response timein the same manner as in Example 11, whereby acontrast ratio of 20.3 was obtained.
EXAMPLE 16
A blank cell was prepared in the same manneras in Example 11 except that a 1.0%-solution ofpolyamide acid (LQ-1802, available from Hitachi KaseiK.K.) in NMP (N-methylpyrrolidone) was formed insteadof the 1.0%-solution of polyimide resin precursor indimethylacetoamide on each electrode plate and thatthe hot curing treatment thereof was effected at 270.degree. C. for 1 hour. A ferroelectric liquid crystal devicewas prepared by filling the blank cell with the liquidcrystal composition N used in Example 12. The liquidcrystal device was subjected to measurement a contrastratio in the same manner as in Example 11, whereby acontrast ratio of 37.8 was obtained.
As is apparent from the above Examples 14, 15 and 16, also in the case of a different devicestructure, the device containing the ferroelectricliquid crystal composition N according to the presentinvention provided a higher contrast ratio similarlyas in Example 12.
Further, when a driving voltage waveformdifferent from that used in Example 11, a liquidcrystal device using the liquid crystal compositionaccording to the present invention provided a highercontrast ratio compared with a liquid crystal deviceusing a liquid crystal composition containing onquinoxaline compound.
EXAMPLE 17
Production of 6-octyl-2-(4-dodecyloxyphenyl)quinoxaline(Ex. Comp. No. I-36)
In a 100 ml-round-bottomed flask, 0.60 g(2.72 mM) of 4-octyl-1,2-phenylenediamine prepared inthe same manner as in Example 1 and 16.8 ml of ethanolwere placed and mixed. To the solution, 1.4 ml of 2N-hydrochoricacid (HCl) was added. To the resultantsolution, 0.92 g (2.73 mM) of 4-decyloxyphenylglyoxalmonohydrate prepared in the same manner as in Example1 was added, followed by stirring for 30 minutes underheat refluxing. After the reaction, the reactionmixture was left standing at room temperature toprecipitate a crystal. The crystal was recovered byfiltration and recrystallized two times from isopropylether and further recrystallized once from acetone.The resultant crystal was purified by silica gelcolumn chromatography (eluent: toluene/ethyl acetate=50/1) and recrystallized from acetone to obtain 0.40 gof 6-octyl-2-(4-dodecyloxyphenyl)quinoxaline (Yield:29.2%). ##STR188##
EXAMPLES 18-23
Six quinoxaline compounds represented by thefollowing formula were prepared in the same manner asin Example 17. ##STR189##
The results were summarized in the followingTable 1.
TABLE 1__________________________________________________________________________ Ex. Comp.Ex. No. No. R R' Phase transition temperature (.degree.C.)__________________________________________________________________________18 I-24 C.sub.4 H.sub.9 C.sub.12 H.sub.25 ##STR190##19 I-172 C.sub.6 H.sub.13 C.sub.10 H.sub.21 ##STR191##20 I-173 C.sub.6 H.sub.13 C.sub.12 H.sub.25 ##STR192##21 I-33 C.sub.8 H.sub.17 C.sub.4 H.sub.9 ##STR193##22 I-34 C.sub.8 H.sub.17 C.sub.6 H.sub.13 ##STR194##23 I-35 C.sub.8 H.sub.17 C.sub.10 H.sub.21 ##STR195##__________________________________________________________________________
EXAMPLE 24
Production of 6-hexanol-2-(4-dodecyloxyphenyl)quinoxaline(Ex. Comp. No. I-191)
4-hexanoylacetanilide obtained fromacetanilide through Friedel-Crafts reaction wassuccessively subjected to nitration, deacetylation andreduction to obtain 4-hexanoyl-1,2-phenylenediamine.
0.12 g (0.58 mM) of the above-prepared 4-hexanoyl-1,2-phenylenediamine,0.20 g (0.59 mM) of 4-dodecyloxyphenylglyoxalmonohydrate and 3 ml ofethanol were placed in a 20 ml-round-bottomed flask,followed by stirring for 20 minutes under heat-refluxing.After the reaction, the reaction mixturewas cooled on an ice bath to precipitate a crystal.The crystal was recovered by filtration and washedwith cooled ethanol, followed by recrystallization twotimes from isopropyl ether to obtain 0.17 g of 6-hexanoyl-2-(4-dodecyloxyphenyl)quinoxaline(Yield: 59.8%). ##STR196##
EXAMPLE 25
Production of 6-octyl-2-(4-octylphenyl)quinoxaline(Ex. Comp. No. I-185)
6-octyl-2-(4-octylphenyl)quinoxaline wasprepared in the same manner as in Example 17 exceptthat 4-octylphenylglyoxal monohydrate was used insteadof 4-dodecyloxyphenylglyoxal monohydrate (Yield: 29.1%). ##STR197##
EXAMPLES 26-28
Three quinoxaline compounds represented by thefollowing formula were prepared in the same manner asin Example 25. ##STR198##
The results were summarized in the followingTable 2.
TABLE 2__________________________________________________________________________Ex. No. Ex. Comp. No. R" Phase transition temperature (.degree.C.)__________________________________________________________________________26 I-183 C.sub.5 H.sub.11 ##STR199##27 I-184 C.sub.7 H.sub.15 ##STR200##28 I-186 C.sub.10 H.sub.21 ##STR201##__________________________________________________________________________
EXAMPLE 29
Production of 6-octyl-2-(4-nonanoyloxyphenyl)quinoxaline(Ex. Comp. No. I-201)
In a 200 ml-round-bottomed flask, 1.50 g(6.81 mM) of 4-octyl-1,2-phenylenediamine and 40 ml ofethanol were placed and mixed. To the solution, 3.4 ml of 2N-HCl was added. To the resultant solution,1.15 g (6.84 mM) of 4-hydroxyphenylglyoxal monohydratewas added, followed by stirring under heat refluxing.After the reaction, 19.1 ml of a solution of potassiumhydroxide in ethanol (0.02 g of KOH/1 ml of EtOH) wasadded to the reaction mixture under stirring at roomtemperature, followed by distilling-off of the solventunder reduced pressure to obtain a residue. Theresidue was dried within a desiccator under reducedpressure. To the resultant residue, 50 ml ofmethylene chloride was added. The insoluble matterwas removed by filtration. To the filtrate, 1.18 g(7.46 mM) of nonanoic acid was added. To theresultant solution, 1.53 g (7.42 mM) of N,N'-dicyclohexylcarbodiimideand 0.18 g of 4-dimethylaminopyridinewere successively added,followed by stirring for 2 hours at room temperature.After the reaction, the reaction mixture was leftstanding overnight at room temperature to precipitateN,N'-dicyclohexylurea. The precipitated N,N'-dicyclohexylureawas removed by filtration and thefiltrate was concentrated under reduced pressure. Tothe resultant residue, an appropriate amount ofmethanol was added thereby to precipitate a crystal.The crystal was recovered by filtration andrecrystallized two times from acetone. The resultantcrystal was purified by silica gel columnchromatography (eluent: toluene/ethyl acetate=50/1),followed by recrystallization from acetone to obtain0.84 g of 6-octyl-2-(4-nonanoyloxyphenyl)quinoxaline(Yield: 26.0%). ##STR202##
EXAMPLE 30
Production of 6-octyl-2-(4-heptanoyloxyphenyl)quinoxaline(Ex. Comp. No. I-199)
6-octyl-2-(4-heptanoyloxyphenyl)quinoxalinewas prepared in the same manner as in Example 29. ##STR203##
EXAMPLE 31
A liquid crystal composition Q was preparedby mixing the following Example Compounds instead ofthose of (I-34), (I-58) and (I-83) used in Example 3 in the indicated proportions with the liquid crystalcomposition
______________________________________Ex.Comp. wt.No. Structural formula parts______________________________________I-173 2 ##STR204##I-185 4 ##STR205##I-196 2 ##STR206##Composition A 92______________________________________
A ferroelectric liquid crystal device wasprepared in the same manner as in Example 2 exceptthat the above liquid crystal composition Q was used,and the device was subjected to measurement of opticalresponse time and observation of switching states. Inthe device, a monodomain with a good and uniformalignment characteristic was observed. The results ofthe measurement are shown
______________________________________ 10.degree. C. 25.degree. C. 40.degree. C.______________________________________Response time (.mu.sec) 508 267 150______________________________________
As apparent from the above Example 31, theferroelectric liquid crystal device including theliquid crystal composition Q, i.e., a compositioncontaining a quinoxaline compound according to thepresent invention, provided improved operationcharacteristic at a lower temperature, high speedresponsiveness and a decreased temperature dependenceof response speed similarly as in Examples 2-8.
EXAMPLE 32
A liquid crystal composition R was preparedby mixing the following Example Compounds instead ofthose of (I-17), (I-87) and (I-140) used in Example13 in the indicated proportions with the liquidcrystal composition
______________________________________Ex.Comp. wt.No. Structural formula parts______________________________________I-104 3 ##STR207##I-119 2 ##STR208##I-148 2 ##STR209##Composition A 93______________________________________
A ferroelectric liquid crystal device wasprepared in the same manner as in Example 11 exceptthat the above liquid crystal composition R was used,and the device was subjected to measurement of acontrast ratio, whereby a contrast ratio of 31.5 wasobtained.
As apparent from the above Example 32, theferroelectric liquid crystal device including theliquid crystal composition R, i.e., a compositioncontaining a quinoxaline compound according to thepresent invention, provided improved a higher contrastratio when driven similarly as in Examples 11-13.
As described hereinabove, according to thepresent invention, by using a liquid crystalcomposition containing at least one quinoxalinecompound of the formula (I), there is provided aliquid crystal device providing improvedcharacteristic such as a good alignmentcharacteristic, a good switching property, high-speedresponsiveness, a decreased temperature-dependence ofresponse speed, and a high contrast ratio.
Claims
  • 1. A quinoxaline compound represented by the following formula (I):
  • R.sub.1 --A.sub.1 --X.sub.1 --A.sub.2 --X.sub.2 --A.sub.3 --R.sub.2(I),
  • wherein
  • R.sub.1 and R.sub.2 independently denote halogen or a linear or branched alkyl group having 2-18 carbon atoms capable of including one or non-neighboring two or more --CH.sub.2 -groups which can be replaced with --O--, --S--, --CO--, --CO--O--, --O--CO--, --CH.dbd.CH-- or --C.ident.C--; said linear or branched alkyl group being capable of including hydrogen which can be replaced with fluorine;
  • X.sub.1 and X.sub.1 independently denote a single bond, --CO--O--, --O--CO--, --CH.sub.2 CH.sub.2 -- OR --C.ident.C--;
  • A.sub.1, A.sub.2 and A.sub.3 independently denote a single bond, 1,4-phenylene, 1-4-phenylene having one or two substituents comprising F, Cl, Br, CH.sub.3, CF.sub.3 or CN; 1,4-cyclohexylene, pyrimidine-2,5-diyl, pyridine-2,5-diyl, thiophene-2,5-diyl, 2,6-naphthylene, thiazole-2,5-diyl, thiadiazole-2,5-diyl, pyrazine-2,5-diyl, pyridazine-3,6-diyl, benzothiazole-2,6-diyl, benzoxazole-2,5-diyl, indan-2,5-diyl, 2-alkylindan-2,5-diyl having a linear or branched alkyl group having 1-18 carbon atoms, coumaran-2,5-diyl, 2-alkylcoumaran-2,5-diyl having a linear or branched alkyl group having 1-18 carbon atoms, guinoxaline-2,6-diyl or quinoxaline-2,7-diyl; with the proviso that:
  • at least one group of A.sub.1, A.sub.2 and A.sub.3 is quinoxaline-2,6-diyl or quinoxaline-2,7-diyl and the remaining two groups of A.sub.1, A.sub.2 and A.sub.3 cannot be a single bond simultaneously; and when A.sub.1 or A.sub.3 is quinoxaline-2,6-diyl and A.sub.2 is 1,4-phenylene, then the remaining A.sub.1 or A.sub.3 cannot be 1,4-phenylene.
  • 2. A compound according to claim 1, which is a quinoxaline compound (Ia) of the formula (I) wherein any one of A.sub.1, A.sub.2 and A.sub.3 is a single bond.
  • 3. A compound according to claim 1, which is any one of the following quinoxaline compounds (Ib) to (Ie) of the formula (I):
  • Compound (Ib) wherein one of A.sub.1 and A.sub.3 is 1,4-phenylene or said 1,4-phenylene having one or two substituents and the other of A.sub.1 and A.sub.3 is quinoxaline-2,6-diyl or quinoxaline-2,7-diyl, and A.sub.2 is selected from pyrimidine-2,5-diyl, pyridine-2,5-diyl, thiadiazole-2,5-diyl, thiazole-2,5-diyl, thiophene-2,5-diyl, pyrazine-2,5-diyl or pyridazine-3,6-diyl;
  • Compound (Ic) wherein A.sub.2 is 1,4-phenylene or said 1,4-phenylene having one or two substituents, and one of A.sub.1 and A.sub.3 is quinoxaline-2,6-diyl or quinoxaline-2,7-diyl, and the other of A.sub.1 and A.sub.3 is selected from pyrimidine-2,5-diyl, pyridine-2,5-diyl, thiadiazole-2,5-diyl, thiazole-2,5-diyl, thiophene-2,5-diyl, pyrazine-2,5-diyl or pyridazine-3,6-diyl;
  • Compound (Id) wherein A.sub.2 is quinoxaline-2,6-diyl or quinoxaline-2,7-diyl, and A.sub.1 and A.sub.3 are independently selected from 1,4-phenylene, said 1,4-phenylene having one or two substituents, pyrimidine-2,5-diyl, pyridine-2,5-diyl, thiadiazole-2,5-diyl, thiazole-2,5-diyl, thiophene-2,5-diyl, pyrazine-2,5-diyl or pyridazine-3,6-diyl; and
  • Compound (Ie) wherein each of A.sub.1 and A.sub.3 is quinoxaline-2,6-diyl or quinoxaline-2,7-diyl, and A.sub.2 is selected from 1,4-phenylene, said 1,4-phenylene having one or two substituents, 1,4-cyclohexylene, pyrimidine-2,5-diyl, pyridine-2,5-diyl, thiadiazole-2,5-diyl, thiazole-2,5-diyl, thiophene-2,5-diyl, pyrazine-2,5-diyl or pyridazine-3,6-diyl.
  • 4. A compound according to claim 1, which is any one of the following compounds (Iaa) to (Iac) of the formula (I):
  • Compound (Iaa) wherein A.sub.1, X.sub.1 and X.sub.2 are a single bond, A.sub.2 is selected from 1,4-phenylene, said 1,4-phenylene having one or two substituents, 1,4-cyclohexylene, pyrimidine-2,5-diyl, pyridine-2,5-diyl, thiophene-2,5-diyl, 2,6-naphthylene, thiazole-2,5-diyl, thiadiazole-2,5-diyl, pyrazine-2,5-diyl, pyridazine-3,6-diyl, benzothiazole-2,6-diyl or benzoxazole-2,5-diyl, and A.sub.3 is quinoxaline-2,6-diyl or quinoxaline-2,7-diyl;
  • Compound (Iab) wherein A.sub.1 and X.sub.1 are a single bond, A.sub.2 is selected from 1,4-phenylene, said 1,4-phenylene having one or two substituents or 1,4-cyclohexylene, X.sub.2 is --CO--O-- or --O--CO--; and A.sub.3 is quinoxaline-2,6-diyl or quinoxaline-2,7-diyl; and
  • Compound (Iac) wherein A.sub.1 and X.sub.1 are a single bond, A.sub.2 is selected from 1,4-phenylene, said 1,4-phenylene having one or two substituents, pyrimidine-2,5-diyl or pyridine-2,5-diyl, X.sub.2 is --C.ident.C-- or --CH.sub.2 CH.sub.2 --, and A.sub.3 is quinoxaline-2,6-diyl or quinoxaline-2,7-diyl
  • 5. A compound according to claim 1, which is any one of the following compounds (Iba) to (Iea) of the formula (I):
  • Compound (Iba) wherein A.sub.1 is 1,4-phenylene or said 1,4-phenylene having one or two substituent, X.sub.1 and X.sub.2 are independently selected from a single bond, --CO--O--, --C.ident.C-- or --CH.sub.2 CH.sub.2 --, A.sub.2 is selected from pyrimidine-2,5-diyl, pyridine-2,5-diyl, thiadiazole-2,5-diyl, thiazole-2,5-diyl thiophene-2,5-diyl or pyrazine-2,5-diyl, and A.sub.3 is quinoxaline-2,6-diyl or quinoxaline-2,7-diyl;
  • Compound (Ica) wherein A.sub.1 is selected from pyrimidine-2,5-diyl, pyridine-2,5-diyl, thiadiazole-2,5-diyl, thiazole-2,5-diyl, thiophene-2,5-diyl, pyrazine-2,5-diyl or pyridazine-3,6-diyl, X.sub.1 and X.sub.2 are independently selected from a single bond, --CO--O--, --C.ident.C-- or --CH.sub.2 CH.sub.2 --, A.sub.2 is 1,4-phenylene or said 1,4-phenylene having one or two substituents, and A.sub.3 is quinoxaline-2,6-diyl or quinoxaline-2,7-diyl;
  • Compound (Ida) wherein X.sub.1 and X.sub.2 are independently selected from a single bond, --C.ident.C-- or --CH.sub.2 CH.sub.2 --, A.sub.2 is quinoxaline-2,6-diyl or quinoxaline-2,7-diyl, A.sub.1 and A.sub.3 are independently selected from 1,4-phenylene, said 1,4-phenylene having one or two substituents, pyrimidine-2,5-diyl, pyridine-2,5-diyl, thiadiazole-2,5-diyl, thiazole-2,5-diyl, thiophene-2,5-diyl, pyrazine-2,5-diyl or pyridazine-3,6-diyl,
  • Compound (Iea) wherein X.sub.1 and X.sub.2 are a single bond, each of A.sub.1 and A.sub.3 is quinoxaline-2,6-diyl or quinoxaline-2,7-diyl, A.sub.2 is selected from 1,4-phenylene, said 1,4-phenylene having one or two substituents, 1,4-cyclohexylene, 2,6-naphthylene, pyrimidine-2,5-diyl, pyridine-2,5-diyl, thiadiazole-2,5-diyl, thiazole-2,5-diyl, thiophene-2,5-diyl, pyrazine-2,5-diyl or pyridazine-3,6-diyl.
  • 6. A compound according to claim 1, wherein R.sub.1 and R.sub.2 in the formula (I) are independently represented by any one of the following groups (i) to (vi):
  • (i) n--C.sub.a H.sub.2a+1 --X.sub.3 --,
  • (ii) ##STR210## (iii) ##STR211## (iv) C.sub.h F.sub.2h+1 .paren open-st.CH.sub.2 .paren close-st..sub.i X.sub.3,
  • (v) ##STR212## and (vi) F,
  • wherein a is an integer of 2-17; d, g and i are an integer of 0-7; b, e and h are an integer of 1-8, f and k are 0 or 1, j is an integer of 1-15; and X.sub.3 denotes a single bond, --O--, --O--CO-- or --CO--O--.
  • 7. A compound according to claim 1, which is an optically active compound.
  • 8. A compound according to claim 1, which is an optically inactive compound.
  • 9. A compound according to any one of claims 1-8, which is a mesomorphic compound.
  • 10. A liquid crystal composition comprising at least two compounds, at least one of which is a quinoxaline compound of the formula (I) according to claim 1.
  • 11. A liquid crystal composition comprising at least two compounds, at least one of which is a quinoxaline compound of the formula (I) according to claim 2.
  • 12. A liquid crystal composition comprising at least two compounds, at least one of which is a quinoxaline compound of the formula (I) according to claim 3.
  • 13. A liquid crystal composition comprising at least two compounds, at least one of which is a quinoxaline compound of the formula (I) according to claim 4.
  • 14. A liquid crystal composition comprising at least two compounds, at least one of which is a quinoxaline compound of the formula (I) according to claim 5.
  • 15. A liquid crystal composition comprising at least two compounds, at least one of which is a quinoxaline compound of the formula (I) according to claim 6.
  • 16. A liquid crystal composition comprising at least two compounds, at least one of which is a quinoxaline compound of the formula (I) according to claim 7.
  • 17. A liquid crystal composition comprising at least two compounds, at least one of which is a quinoxaline compound of the formula (I) according to claim 8.
  • 18. A liquid crystal composition according to claim 10, wherein said quinoxaline compound of the formula (I) is a mesomorphic compound.
  • 19. A liquid crystal composition according to claim 10, which comprises 1-80 wt. % of a quinoxaline compound of the formula (I).
  • 20. A liquid crystal composition according to claim 10, which comprises 1-60 wt. % of a quinoxaline compound of the formula (I).
  • 21. A liquid crystal composition according to claim 10, which comprises 1-40 wt. % of a quinoxaline compound of the formula (I).
  • 22. A liquid crystal composition according to claim 10, which has a chiral smectic phase.
  • 23. A liquid crystal device, comprising a liquid crystal composition according to any one of claims 10 -22.
  • 24. A liquid crystal device, comprising a pair of electrode plates and a liquid crystal composition according to claim 23 disposed between the electrode plates.
  • 25. A liquid crystal device according to claim 24, which further comprises an alignment control layer.
  • 26. A liquid crystal device according to claim 25, wherein the alignment control layer has been subjected to rubbing.
  • 27. A liquid crystal device according to claim 24, wherein the liquid crystal composition is disposed in a thickness suppressing formation of a helical structure of liquid crystal molecules between the electrode plates.
  • 28. A display apparatus including a display panel comprising a liquid crystal device according to claim 24.
  • 29. A display apparatus according to claim 28, which further comprises a drive circuit.
  • 30. A display apparatus according to claim 29, which further comprises a light source.
  • 31. A display method, comprising:
  • providing a liquid crystal composition according to any one of claims 10-22; and
  • controlling the alignment direction of liquid crystal molecules in accordance with image data thereby to obtain a desired display image.
Priority Claims (2)
Number Date Country Kind
5-101039 Apr 1993 JPX
6-064904 Apr 1994 JPX
US Referenced Citations (7)
Number Name Date Kind
3900473 Diel et al. Aug 1975
4367924 Clark et al. Jan 1983
4402849 Krause et al. Sep 1983
5091109 Takiguchi et al. Feb 1992
5173211 Yamashita et al. Dec 1992
5236619 Iwaki et al. Aug 1993
5244596 Takiguchi et al. Sep 1993
Foreign Referenced Citations (2)
Number Date Country
0029958 Jun 1981 EPX
60-260504 Dec 1985 JPX
Non-Patent Literature Citations (10)
Entry
Dvolaitzky et al, Tetrahedron, vol. 32, No. 14 (1976) 1835-8.
Diele et al. Mol. Crys. Liq. Crys., vol. 17, No. 2 (1972) 163-169.
Herrmann et al., Z. Phys. Chemie, Leipzig, vol. 257, No. 3 (1976) 563-76.
Schubert et al. J. Prakt. Chem., vol. 4, No. 33 (1966) 265-76.
Schadt et al. Appl. Phys. Lett., vol. 18, No. 4 (1971) 127-8.
Macromolecules, vol. 25, No. 24 (Nov. 1992) pp. 6711-6713.
Mol. Crystals & Liq. Cyrstals Bulletin, vol. 15, No. 4 (1972) pp. 363-366.
Mol. Crystals & Liq. Crystals Bulletin, vol. 51 (1979) pp. 250-251.
Derwent Patent Abstract No. 93-154999 (Apr. 9, 1993) JP 5/88388.
Derwent Patent Abstract No. 93-04032 (Dec. 21, 1992) JP 4/368953.